Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Amylyx Pharmaceuticals, Inc., in collaboration with the Alzheimer’s Association, the Alzheimer’s Drug Discovery Foundation (ADDF) and the Cure…
Euronext listed biopharma company Probiodrug AG, a clinical stage developer therapeutics to treat Alzheimer’s disease (AD), has announced that results…
Eli Lilly and AstraZeneca have announced a worldwide agreement to co-develop MEDI1814, an antibody selective for amyloid-beta 42 (Aβ42), which…
Low levels of breast cancer factor 1 (BRCA1) protein in the brain may contribute to dementia, according to results of a National Institutes of Health (NIH)-funded study, published in Nature Communications.
Anavex Life Sciences Corp, a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous system (CNS)…
Allergan has announced a nationwide partnership with the Caregiver Action Network (CAN), a family caregiver organization, to provide thank you meals to 1,000…
Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous system (CNS)…